|
|
Volumn 30, Issue 1, 2001, Pages 89-90
|
|
Heparin thromboprophylaxis after acute stroke [5]
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTICOAGULANT AGENT;
HEPARIN;
ACUTE DISEASE;
BRAIN HEMORRHAGE;
BRAIN ISCHEMIA;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEATH;
DOSE RESPONSE;
DRUG EFFICACY;
HUMAN;
LEG COMPRESSION;
LETTER;
LUNG EMBOLISM;
PRIORITY JOURNAL;
PROPHYLAXIS;
RANDOMIZED CONTROLLED TRIAL;
RECURRENCE RISK;
RISK ASSESSMENT;
STROKE;
THROMBOSIS;
TREATMENT CONTRAINDICATION;
TREATMENT OUTCOME;
ACUTE DISEASE;
AGED;
ASPIRIN;
CAUSE OF DEATH;
CEREBRAL HEMORRHAGE;
CEREBRAL INFARCTION;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG THERAPY, COMBINATION;
FEMALE;
HEPARIN;
HUMANS;
MALE;
SURVIVAL ANALYSIS;
SURVIVAL RATE;
VENOUS THROMBOSIS;
|
|
EID: 0035066882
PISSN: 00020729
EISSN: None
Source Type: Journal
DOI: 10.1093/ageing/30.1.89 Document Type: Letter |
|
Times cited : (1)
|
|
References (5)
|
